Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy

This publication has 39 references indexed in Scilit:

• Estimating AIDS-Free Survival in a Severely Immunosuppressed Asymptomatic HIV-Infected Population in the Era of Antiretroviral Triple Combination Therapy
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
• Recovery of the Immune System With Antiretroviral Therapy
  JAMA, 1998
• Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1998
• Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy
  JAMA, 1998
• Effect of HAART on natural history of AIDS-related opportunistic disorders
  The Lancet, 1998
• Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
  BMJ, 1997
• Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy
  AIDS, 1997
• A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
  New England Journal of Medicine, 1997
• HIV-1 Protease Inhibitors
  JAMA, 1997
• A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 Infection
  New England Journal of Medicine, 1995